PD-1 drugs for Breast Cancer
2 tracked PD-1 drugs in the Breast Cancer race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Breast Cancer page.
2 approved / phase 4
Head-to-head evidence: Pembrolizumab vs Pembrolizumab berahyaluronidase alfa